These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9422584)

  • 41. Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: a prospective phase II study.
    Lindholm P; Valavaara R; Aitasalo K; Kulmala J; Laine J; Elomaa L; Sillanmäki L; Minn H; Grénman R
    Radiother Oncol; 2006 Feb; 78(2):146-51. PubMed ID: 16307813
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alteration of radiotherapy fractionation and concurrent chemotherapy: a new frontier in head and neck oncology?
    Bernier J
    Nat Clin Pract Oncol; 2005 Jun; 2(6):305-14. PubMed ID: 16264988
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mucositis versus tumor control: the therapeutic index of adding chemotherapy to irradiation of head and neck cancer.
    Lee IH; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1060-3. PubMed ID: 19304406
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Radiation treatment of head and neck cancer.
    Yom SS
    Surg Oncol Clin N Am; 2015 Jul; 24(3):423-36. PubMed ID: 25979392
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hyperfractionated accelerated radiotherapy versus conventional fractionation both combined with chemotherapy in patients with locally advanced head and neck carcinomas: a retrospective analysis of a monoinstitutional series.
    Welz H; Pöttgen C; Abu Jawad J; Wierlemann A; Wittig A; Stüben G; Budach V; Lehnerdt G; Jahnke K; Sack H; Stuschke M
    Oncology; 2009; 76(6):405-12. PubMed ID: 19407473
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Radiation Therapy Oncology Group (RTOG) trials for head and neck cancer.
    Cox JD; Fu KK; Pajak TF; Cooper JS; Ang KK
    Rays; 2000; 25(3):321-3. PubMed ID: 11367897
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial.
    Bentzen SM; Atasoy BM; Daley FM; Dische S; Richman PI; Saunders MI; Trott KR; Wilson GD
    J Clin Oncol; 2005 Aug; 23(24):5560-7. PubMed ID: 16110017
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Concurrent weekly docetaxel and hyperfractionated radiotherapy for advanced head and neck cancer.
    Matsumoto F; Karasawa K; Itoh S; Toda M; Haruyama T; Furukawa M; Ikeda K
    Anticancer Res; 2006; 26(5B):3781-6. PubMed ID: 17094401
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Hyperfractionated radiation therapy for head and neck cancers].
    Karasawa K; Hanyu N; Chang TC; Kuga G; Kaminuma T; Mitsuhashi T; Miyashita H
    Gan To Kagaku Ryoho; 2008 Nov; 35(11):1827-32. PubMed ID: 19011330
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improving outcomes in head and neck cancer.
    James N; Hartley A
    Clin Oncol (R Coll Radiol); 2003 Aug; 15(5):264-5. PubMed ID: 12924457
    [No Abstract]   [Full Text] [Related]  

  • 51. Statistical response to Dr. J. M. Brown, IJROBP 32:883-885; 1995.
    Cosmatos D; Pajak TF
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):1265-6. PubMed ID: 7607955
    [No Abstract]   [Full Text] [Related]  

  • 52. Comparative role of real-world study and traditional randomized controlled trials in head and neck cancer: a literature-based analysis.
    Zhu GL; Xu C; Tang SQ; Chen L; Mao YP; Tang LL; Zhou GQ; Liu Q; Sun Y; Ma J
    Chin Med J (Engl); 2020 Nov; 134(4):489-491. PubMed ID: 33237696
    [No Abstract]   [Full Text] [Related]  

  • 53. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.
    Bourhis J; Overgaard J; Audry H; Ang KK; Saunders M; Bernier J; Horiot JC; Le Maître A; Pajak TF; Poulsen MG; O'Sullivan B; Dobrowsky W; Hliniak A; Skladowski K; Hay JH; Pinto LH; Fallai C; Fu KK; Sylvester R; Pignon JP;
    Lancet; 2006 Sep; 368(9538):843-54. PubMed ID: 16950362
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quality assurance of radiation therapy for head and neck cancer patients treated in DAHANCA 10 randomized trial.
    Hansen CR; Johansen J; Kristensen CA; Smulders B; Andersen LJ; Samsøe E; Andersen E; Petersen JB; Overgaard J; Grau C
    Acta Oncol; 2015; 54(9):1669-73. PubMed ID: 26206516
    [No Abstract]   [Full Text] [Related]  

  • 55. [Radiochemotherapy in head and neck neoplasms].
    Munker R; Reitmeier M; Hartenstein R
    Strahlenther Onkol; 2000 Nov; 176(11):537-8. PubMed ID: 11143531
    [No Abstract]   [Full Text] [Related]  

  • 56. Outcome of hyperfractionated radiation therapy in randomized clinical trials.
    Willers H; Liertz-Petersen C; Dubben HH; Beck-Bornholdt HP
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):257-9. PubMed ID: 9422584
    [No Abstract]   [Full Text] [Related]  

  • 57. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck.
    Budach W; Hehr T; Budach V; Belka C; Dietz K
    BMC Cancer; 2006 Jan; 6():28. PubMed ID: 16448551
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.